Metadherin Impairs PPARα ‐Mediated Fatty Acid Oxidation to Aggravate Renal Lipotoxicity in Diabetic Kidney Disease
The FASEB Journal · 15.11.2026 · 40 (21)
DOI: 10.1096/fj.202602428r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 07.11.2026. Verfasst von Wen-Ting Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: PPAR alpha, Diabetic Nephropathies, RNA-Binding Proteins, Fatty Acids. Die Arbeit nennt 59 Literaturangaben. Gefördert von: The Guangxi Science and Technology Program (Guangxi Natural Science Foundation), National Natural Science Foundation of China (NSFC), Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Impaired fatty acid oxidation (FAO) and subsequent lipotoxicity in renal tubules play a key role in diabetic kidney disease (DKD) progression; however, the underlying mechanisms remain unclear. Metadherin (MTDH) is linked to DKD; however, its potential role in renal lipotoxicity remains poorly characterized. A DKD murine model was established via unilateral nephrectomy, a high‐fat diet, and streptozotocin (STZ) injection. Palmitic acid (PA)‐stimulated renal tubular epithelial cells (RTECs) were also used. Renal MTDH in mice was knocked down using an adeno‐associated virus serotype 9 (AAV9) vector, and MTDH was silenced or overexpressed in vitro. In mice, MTDH knockdown improved renal function, enhanced FAO via peroxisome proliferator‐activated receptor alpha (PPARα), and reduced lipotoxicity. In vitro, MTDH silencing mitigated lipid accumulation and activated FAO, whereas overexpression aggravated the injury, an effect that was reversed by a PPARα agonist. In conclusion, MTDH upregulation in the diabetic kidney disrupts lipid homeostasis by repressing PPARα‐mediated FAO, thereby promoting lipotoxic injury. These findings offer new insights into DKD metabolic dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Wen-Ting Liu
Förderung
- The Guangxi Science and Technology Program (Guangxi Natural Science Foundation)
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Liu, W. T., Lan, S. F., Li, J., Chen, K. N., Long, H. B., Feng, L., Wu, Q. Y., Song, Y. S., Wang, M. J., & Yang, Z. H. (2026). Metadherin Impairs PPARα ‐Mediated Fatty Acid Oxidation to Aggravate Renal Lipotoxicity in Diabetic Kidney Disease. The FASEB Journal, 40(21). https://doi.org/10.1096/fj.202602428r
Vancouver
Liu WT, Lan SF, Li J, Chen KN, Long HB, Feng L, et al. Metadherin Impairs PPARα ‐Mediated Fatty Acid Oxidation to Aggravate Renal Lipotoxicity in Diabetic Kidney Disease. The FASEB Journal. 2026;40(21). doi:10.1096/fj.202602428r
BibTeX
@article{Liu2026,
author = {Liu, Wen-Ting and Lan, Shan-Fen and Li, Juan and Chen, Kun-Ni and Long, Hai-Bo and Feng, Li and Wu, Qiao-Yuan and Song, Ya-Shan and Wang, Ming-Jun and Yang, Zhen-Hua},
title = {Metadherin Impairs PPARα ‐Mediated Fatty Acid Oxidation to Aggravate Renal Lipotoxicity in Diabetic Kidney Disease},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {21},
doi = {10.1096/fj.202602428r}
}
EUVIMED